@ARTICLE{
author={Petzer Andreas L,...,Bogdanovic Andrija D,...,(broj koautora 20)},
year={2012},
title={High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients - final analysis of a randomized, multicenter, phase III trial},
journal={HAEMATOLOGICA-THE HEMATOLOGY JOURNAL},
volume={97},
number={10},
pages={1562-1569},
document_type={Article},
} 

@ARTICLE{
author={Petzer Andreas L,Wolf Dominik,Fong Dominic,Lion Thomas,Dyagil Irina,Masliak Zvenyslava,Bogdanovic Andrija D,Griskevicius Laimonas,Lejniece Sandra,Goranov Stefan,Gercheva Liana,Stojanovic Aleksandar,Peytchev Dontcho,Tzvetkov Nikolay,Griniute Rasa,Oucheva Radka,Ulmer Hanno,Kwakkelstein Marthin,Rancati Francesca,Gastl Guenther A},
year={2010},
title={High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study},
journal={HAEMATOLOGICA-THE HEMATOLOGY JOURNAL},
volume={95},
number={6},
pages={908-913},
document_type={Article},
}